CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Dyspepsia - proven non-ulcer - Drugs in this topic
Scenario: Management of non-ulcer dyspepsia
This level contains the following sections:
- Acidex liquid aniseed
- Altacite Plus oral suspension
- Asilone oral suspension
- Co-magaldrox 195mg/220mg/5ml oral suspension sugar free
- Esomeprazole 20mg gastro-resistant tablets
- Famotidine 20mg tablets
- Gastrocote chewable tablets
- Gastrocote liquid
- Gaviscon Advance chewable tablets
- Gaviscon Advance oral suspension aniseed
- Gaviscon Advance oral suspension peppermint
- Hydrotalcite 500mg/5ml oral suspension
- Lansoprazole 15mg gastro-resistant capsules
- Lansoprazole 30mg gastro-resistant capsules
- Maalox Plus oral suspension
- Magnesium trisilicate oral suspension
- Nizatidine 150mg capsules
- Omeprazole 10mg gastro-resistant capsules
- Omeprazole 20mg gastro-resistant capsules
- Pantoprazole 20mg gastro-resistant tablets
- Pantoprazole 40mg gastro-resistant tablets
- Peptac liquid aniseed
- Peptac liquid peppermint
- Rabeprazole 10mg gastro-resistant tablets
- Rabeprazole 20mg gastro-resistant tablets
- Ranitidine 150mg tablets
- Rennie Dual Action Liquid oral suspension
- Topal chewable tablets
© NHS Institute for Innovation and Improvement